Synopsis of recent research by authors named "Ben Quan Qi"
- Ben Quan Qi's recent research primarily focuses on pediatric hematological malignancies, particularly acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), emphasizing the significance of minimal residual disease (MRD) monitoring and prognostic stratification using molecular methods like circulating tumor DNA (ctDNA) analysis.
- His studies reveal promising results for early detection and individualized treatment strategies, as seen in his work on ctDNA for AML and cladribine's improved outcomes in relapsed/refractory AML in children, thereby contributing to enhanced treatment protocols.
- Additionally, Quan Qi investigates the clinical features and prognostic factors in various leukemia subtypes, highlighting relationships between specific clinical characteristics, treatment regimens, and patient outcomes, thereby aiding in the development of more refined risk stratification models.
